Ionis and AstraZeneca's WAINZUA Recommended for EU Approval for Hereditary Amyloidosis Treatment

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced that Ionis' and AstraZeneca's WAINZUA (eplontersen) has been recommended for approval by the Comm...

October 22, 2024 | Tuesday | News
Catalent CEO John Chiminski Issues Open Letter Addressing Novo Holdings’ Acquisition and Reaffirms Commitment to Customers

Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, issued the following open lette...

October 22, 2024 | Tuesday | News
Innovent Biologics Announces Successful Phase 2 Results for Picankibart in Treating Ulcerative Colitis

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

October 17, 2024 | Thursday | News
AtomVie and Radiopharm Ventures Partner to Develop Targeted Radiopharmaceutical 177Lu-BetaBart

AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), has entered into an agreeme...

October 16, 2024 | Wednesday | News
Avirmax Biopharma to Showcase Innovative Gene Therapy Advances at AAO 2024

Avirmax Biopharma Inc. (ABI) team will attend AAO 2024, the American Academy of Ophthalmology's annual meeting in Chicago, October 17-21, 20...

October 16, 2024 | Wednesday | News
Merck Opens €290 Million State-of-the-Art Biosafety Testing Facility in Maryland, Accelerating Global Drug Development

Note: Merck operates as MilliporeSigma in North America.   Facility consolidates biosafety testing, analytical development, and cell bank manufact...

October 10, 2024 | Thursday | News
Symbiosis Expands with £1.2M Barclays-Financed Acquisition of New 20,000 Sq/Ft Stirling Facility to Boost High-Tech Medicine Production

    Symbiosis acquires a 20,000 sq/ft building in Stirling, UK, to house new high-tech medicines manufacturing capacity, financed by £1...

October 09, 2024 | Wednesday | News
NovaCina Expands Perth Facility with Advanced SA25 GMP Filling Line to Enhance Global CDMO Services

NovaCina, a global contract development and manufacturing organization (CDMO), has today announced the expansion of its facility in Perth, Australia with...

October 08, 2024 | Tuesday | News
Eli Lilly Invests $4.5 Billion in Medicine Foundry to Transform Drug Development and Manufacturing in Indiana

Indiana facility will combine research, manufacturing and the latest technology to innovate new production methods and scale glo...

October 07, 2024 | Monday | News
Renaissance Lakewood Begins U.S. Manufacturing of FDA-Approved neffy®, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis

Renaissance Lakewood, LLC (“Renaissance”), a leading global contract development and manufacturing organization (“CDMO”) is proud...

October 04, 2024 | Friday | News
Recipharm and Exela Pharma Forge Strategic Alliance to Boost U.S. Sterile Manufacturing with 100+ Million Units Capacity

Sterile manufacturing capability in the US with over 100 million readily-available units (including vials and Pre-Filled Syringes – PFS) Extensi...

October 04, 2024 | Friday | News
Alora Pharmaceuticals Champions ADHD Awareness Month: Empowering the ADHD Community

This ADHD Awareness Month, we stand with the ADHD community. Alora Pharmaceuticals, LLC, the largest U.S. manufacturer of methylphenidate medications,...

October 02, 2024 | Wednesday | News
Piramal Pharma Commits $80M to Transform Lexington Facility, Elevating Global Sterile Injectables Production

$80M investment plan will add commercial scale sterile injectables capabilities Expansion will significantly increase pr...

October 01, 2024 | Tuesday | News
Cytiva Opens Innovation Hub in Songdo, Set to Transform Biopharma Manufacturing in South Korea

The Innovation Hub located in Songdo, Incheon will encompass a manufacturing facility together with a customer experience lab. Operations of the manufac...

September 30, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close